ArticleScientific reports2025
Effects of intranasal neural stem cells transplantation on olfactory epithelium regeneration in an anosmia-induced mouse model.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Global research trends and hotspot evolution of olfactory dysfunction from 2014 to 2024: a bibliometric analysis.Annals of medicine and surgery (2012) · 2026Review
- Stem Cells and Cell-Free Therapies for Olfactory Epithelium Regeneration: Insights from Experimental Models.International journal of molecular sciences · 2025Review
Corrections and comments
- Erratum issued
Authors and funding
8 authors.
Funding
Abstract
This study aims to investigate the efficacy of intranasally transplanted neural stem cells (NSCs) in anosmia-induced mice. Twenty-four male mice were included in the study. A food-finding test (FFT) was performed beforehand to confirm that all mice had normal olfactory functions. The mice were then randomly divided into two groups (Groups 1 and 2) and anosmia was induced by 3-methylindole (3-MI). In the first week following the 3-MI injection (week 1), mice in Group 1 received intranasal saline, while mice in Group 2 received intranasal NSCs. The NSCs were prepared from green fluorescent protein (GFP)-transgenic mice. Olfactory function was evaluated through weekly FFTs. One week after NSC or saline administration (week 2), half of the mice in each group were randomly selected and sacrificed for histological examination. The remaining mice were sacrificed for histological examination in week 4. At week 4, the olfactory epithelium of all mice was also examined by polymerase chain reaction (PCR) to detect GFP + cells. The NSC group showed significantly shorter FFT times compared to the saline group. Epithelial damage scores, indicating greater injury, were higher in the saline group, whereas the NSC group exhibited greater epithelial thickness. Immunohistochemical analysis revealed a significantly higher number of olfactory marker protein-expressing cells in the NSC group. GFP + cells were observed in olfactory bulb (OB) and olfactory epithelium (OE) in the NSC group. PCR confirmed the presence of the GFP gene in the OE of NSC-transplanted mice. Intranasal NSCs promoted functional recovery and GFP + cell integration, supporting further research into their therapeutic potential for olfactory dysfunction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.